SBI Healthcare Opportunities Fund · Regular · Growth
NAV
₹541.2758
as of 13 Nov 2026
Expense Ratio
1.98%
AUM
₹5,565 Cr
Lumpsum returns (CAGR)
- 1Y
- +24.82%
- 3Y
- +24.14%
- 5Y
- +19.39%
- Since Inception
- +15.75%
SIP returns (XIRR)
- 1Y
- +36.22%
- 3Y
- +20.60%
- 5Y
- +22.79%
- Since Inception
- +16.67%
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹17,00,929 today — ₹6,00,000 invested, 20.0% XIRR.
₹6,00,000
Invested
₹17,00,929
Value today
20.0%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹4,02,027 today (14.9% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹23,19,343.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹17,00,929 in this fund vs ₹11,99,859 in the benchmark — outperformance of ₹5,01,070.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹5,26,631 today (5.27×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.98
Sharpe Ratio
+0.16
Alpha
0.61
Beta
1.01
Sortino
12.58%
Std Dev
-10.33%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Sept 2026- Pharmaceuticals & Biotechnology63.10%
- Healthcare Services25.64%
- Chemicals & Petrochemicals4.96%
- Healthcare Equipment & Supplies1.82%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about SBI Healthcare Opportunities Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.11.14%
- 2Divi'S Laboratories Ltd.7.91%
- 3Acutaas Chemicals Ltd.5.03%
- 4Apollo Hospitals Enterprise Ltd.4.45%
- 5Torrent Pharmaceuticals Ltd.4.42%
- 6Cipla Ltd.4.40%
- 7Laurus Labs Ltd.4.05%
- 8Max Healthcare Institute Ltd.3.80%
- 9Aurobindo Pharma Ltd.3.42%
- 10Aster Dm Quality Care Ltd.3.21%
What this fund does
SBI Healthcare Opportunities Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 27 years. It manages assets worth ₹5,565 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TRI. The current expense ratio is 1.98%.